If you’re on the hunt for finance job, it helps to know of some new firms that have launched relatively under-the-radar. Over the past month, these are some of the most interesting new hedge funds and boutiques to have set up shop.
A London-based global event-driven fund launched by former partners at BTG Pactual and senior Goldman Sachs traders, Anavio Capital Partners got the thumbs up from the Financial Services Authority in London in August. Emiliano Leggieri, a former BTG portfolio manager, is founding partner along with Dario Sacchetti, who was previously head of private placements at Goldman Sachs.
The London-based new vehicle of Edouard de Langlade, who was previously at Moore Capital Management, EDL was also approved by the UK regulator in August and focuses on global macro trends. Andrew Porter is COO, who joins from BCM Partners along with execution trader Joseph Dearden. Jannick Wenger is head of investor relations.
A London-based quant fund with the auspicious backing of Swedish hedge fund manager Brummer & Partners, Florin Court was unveiled earlier this year by Douglas Greenig, formerly chief risk officer at Man Group. It’s now been given the go-ahead by the FCA, and has also brought in David Dennison, the former head of FX at AHL, as deputy CIO, Anthony Vinitsky, who was head of investment operations at AHL, as COO and Simon Nichols, who was head of systematic portfolio research at G-Research, as chief technology officer. Further down the tree, Alex Smyth recently joined as a trader from Brevan Howard’s systematic trading fund.
A new boutique investment bank in London focused on the metals and mining and oil and gas sectors, NRG Capital is led by Julian Vickers, the former co-head of natural resources investment banking at Barclays who left in July. NRG was given the go-ahead by UK regulators in August, but has already been building its team. Mick Oliver, the former head of mining at CIBC and Tuikka Alaviitala, the ex-head of oil and gas execution M&A at Barclays have both joined. Vickers told us that he’ll be hiring selectively going forward.
A niche new hedge fund that intends to invest in therapeutics and biotechnology industries, Ikarian Capital was launched in the US earlier this month. The unusual fact about this launch is the background of the fund’s two founders. One is a lawyer and the other – Dr Neil Shahrestani – is a medical doctor who went on to work in the healthcare teams of Goldman Sachs and SAC Capital.
Based in Hong Kong, Zaaba Capital is the new venture of Mohan Rajazooria, a trader who left Azentus Capital Management earlier this year. He’s a big hitter in the Asian hedge fund space –he was a managing director in Goldman Sachs’ principal strategies prop trading team and followed Morgan Aze from the US bank to start up Azentus in 2011.